Cagrilintide 5 mg and 10 mg

Research Peptide for Appetite Regulation · Metabolic Balance · Weight-Management Studies

Cagrilintide 5 mg and 10 mg are research-grade peptides formulated for studies investigating energy regulation, satiety, and metabolic adaptation. A synthetic analog of the naturally occurring hormone amylin, Cagrilintide interacts with amylin and calcitonin receptors to influence appetite control, gastric emptying, and body-weight homeostasis.

Developed for laboratory use only, Cagrilintide 5 mg and 10 mg provide consistent, measurable dosing for both standard and advanced experimental models assessing appetite signaling and energy expenditure.

Scientific Overview

Cagrilintide is a long-acting amylin receptor agonist engineered to resist rapid enzymatic degradation. By binding to amylin and calcitonin receptors, it modulates neural pathways responsible for satiety and glucose regulation.
Preclinical data show that Cagrilintide 5 mg and 10 mg may reduce food intake, delay gastric emptying, and support improved metabolic efficiency without the glycemic instability seen in many anorectic agents.

Key Research Applications

Researchers utilize Cagrilintide 5 mg and 10 mg in studies focused on:

• Appetite Regulation – Evaluating amylin-pathway effects on hunger suppression and food consumption.
• Energy Expenditure – Measuring thermogenesis and resting-metabolic-rate changes following peptide exposure.
• Body-Weight Management – Investigating mechanisms contributing to adiposity reduction.
• Glycemic Control Models – Observing improved post-prandial glucose stability.
• Combination Therapies – Exploring synergy with GLP-1 analogs and other incretin-based compounds for additive metabolic outcomes.

Because Cagrilintide acts through both central and peripheral receptors, it offers a unique research opportunity to study dual-pathway appetite and energy-balance regulation.

Mechanism of Action

Cagrilintide 5 mg and 10 mg mimic endogenous amylin activity by binding to amylin and calcitonin receptors in the hypothalamus and gastrointestinal tract.
This interaction produces several observable effects in research models:

• Reduced Gastric Emptying Rate – Extends satiety and meal spacing.
• Decreased Caloric Intake – Lowers appetite signals via central receptor activation.
• Improved Glucose Response – Enhances insulin sensitivity and glycemic stability.
• Weight Regulation – Promotes sustained body-mass reduction over time in metabolic studies.

Cagrilintide’s extended half-life allows weekly-interval experimentation, simplifying long-term metabolic protocols.

Formulation and Strengths

GRAM Peptides supplies Cagrilintide as lyophilized powder for sterile reconstitution under laboratory conditions:

• Cagrilintide 5 mg – designed for baseline appetite and energy-intake studies.
• Cagrilintide 10 mg – suited for extended or large-model metabolic research requiring higher exposure.

All vials are batch-tested for purity, potency, and identity, ensuring reproducible experimental results.

Why Researchers Choose GRAM Peptides

• Pharmacist-Formulated – Developed by a licensed compounding pharmacist with over 20 years of peptide experience.
• Made in the USA – Manufactured under ISO-compliant clean-room conditions.
• Third-Party Tested – Independent laboratory verification of purity and potency.
• Transparent Labeling – Every Cagrilintide 5 mg and 10 mg vial includes full lot data and COA documentation.

When sourced from GRAM Peptides, investigators receive authentic, research-grade material designed for scientific precision and consistency.

Common Research Areas

• Satiety and appetite-pathway mapping
• Obesity and metabolic-syndrome models
• Glucose-regulation and insulin-sensitivity research
• Combination therapy with GLP-1 and amylin analogs
• Long-term energy-balance investigations

For literature references, researchers often consult the National Library of Medicine (PubMed) for peer-reviewed data on amylin analogs and metabolic modulation.

Frequently Asked Questions

What are Cagrilintide 5 mg and 10 mg used for in research?
They are studied for appetite suppression, energy regulation, and glucose-stability mechanisms.

Why are two strengths offered?
The 5 mg concentration is suited for foundational metabolic research; 10 mg provides a higher-dose option for extended protocols.

Is Cagrilintide FDA-approved?
No. Cagrilintide 5 mg and 10 mg are for Research Use Only (RUO) and not approved for human or veterinary therapeutic applications.

How is the peptide supplied?
Each vial contains lyophilized powder ready for sterile reconstitution before use in controlled laboratory environments.

Related Peptides for Metabolic Research

• Tirzepatide – GLP-1/GIP analog studied for weight-management and insulin-response modulation.
• CJC-1295 + Ipamorelin – Growth-hormone secretagogue combination investigated for recovery and metabolism.
• KPV – Examined for gut-inflammation and immune-balance effects.

Explore the full Metabolic & Weight Support Collection from GRAM Peptides for complementary studies.

Disclaimer

Cagrilintide 5 mg and 10 mg are sold for Research Use Only (RUO). Not for human consumption, medical, or diagnostic use.